AI developers are keen on DA imaging analysis, and the only secret is more AI. The Israel-based company has already received some FDA approvals for AI technology executives and is now planning to use Intel's own detailed learning plan to enhance its software analytics capabilities. In a collaboration announced this week, DIA announced that it will use Intel's OpenVINO toolkit to reduce processing time for its Lvvo seamless echocardiography platform. Using an AI solution like LVivo, Cardiac Ultrasound automatically moves to a hospital server, "behind the scenes" for visual selection and measurement. Includes multiple manual and visual procedures DIA CEO and co-founder Hila Goldman Aslan.